Skip to main content
logo
Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
4.210
+0.760 (22.03%)
At close: Aug 3, 2026, 4:00 PM EDT
4.250
+0.040 (0.95%)
After-hours: Aug 3, 2026, 7:54 PM EDT

Camp4 Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Cap
219318105--
Market Cap Growth
557.29%202.56%---
Enterprise Value
121.52210.6249.6100
Last Close Price
4.216.135.22--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
55.5790.96161.29--
PB Ratio
7.076.671.67--
P/TBV Ratio
5.423.900.39--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
EV/Sales Ratio
30.8960.2176.08--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.060.040.09-0.07-0.13
Net Debt / Equity Ratio
-3.14-2.25-0.880.210.91
Net Debt / EBITDA Ratio
1.912.111.080.521.60
Net Debt / FCF Ratio
3.703.611.210.581.66
Asset Turnover
0.040.040.010.000
Quick Ratio
5.977.066.674.9210.47
Current Ratio
6.157.356.925.1310.62
Return on Equity (ROE)
-127.28%-145.07%170.97%48.98%57.00%
Return on Assets (ROA)
-47.05%-53.60%-79.68%-65.88%-43.88%
Return on Invested Capital (ROIC)
-1374.49%-555.64%-318.71%-266.69%-219.41%
Return on Capital Employed (ROCE)
-54.96%-61.47%-91.65%-73.20%-47.57%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Buyback Yield / Dilution
-314.35%-547.76%-1087.44%-10.71%-
Total Shareholder Return
-314.35%-547.76%-1087.44%-10.71%-
SEC Filings: 10-K · 10-Q